1. The Economics of Shared Care Packages

   • Sarah M. McGhee
   • Anthony J. Hedley

   Leading Article 03 December 2012 Pages: 197 - 204

2. Interferon-α in Hepatitis C

   • Andrew Briggs
   • Alan Shiell

   Leading Article 03 December 2012 Pages: 205 - 209

3. An Historical Survey of UK Government Measures to Control the NHS Medicines Expenditure from 1948 to 1996

   • John P. Griffin

   Review Article 03 December 2012 Pages: 210 - 224

4. Economic Implications of Resistance to Antimalarial Drugs

   • Margaret Phillips
   • Penelope A. Phillips-Howard

   Review Article 03 December 2012 Pages: 225 - 238

5. Cost Saving of 5-day Therapy with Cefpodoxime Proxetil versus Standard 10-day β-Lactam Therapy for Recurrent Pharyngotonsillitis in Adults

   • Alain Pelc
   • Henri Portier
   • Françoise Ichou

   Original Research Article 29 November 2012 Pages: 239 - 250

6. Dynamic Competition as an Exploratory Model of Healthcare Policy for the Antihypertensive Market

   • Robert J. Bonk
   • Maven J. Myers
   • William F. McGhan

   Original Research Article 03 December 2012 Pages: 251 - 261

7. A Comparison of the Cost Effectiveness of Alternative Prophylactic Therapies in Childhood Asthma

   • Philip C. Booth
   • Nicholas E. J. Wells
   • Alan K. Morrison

   Original Research Article 03 December 2012 Pages: 262 - 268

8. Impact of Selective Financing of Drugs on Pharmaceutical Expenditure Control in the Province of Valladolid, Spain

   • Maria A. de Marino
   • Jose M. Marqués
   • Alfonso Velasco

   Original Research Article 03 December 2012 Pages: 269 - 280

9. Streptokinase

   • Jane C. Gillis
   • Karen L. Goa

   Pharmacoeconomic Drug Evaluation 03 December 2012 Pages: 281 - 310

10. Glossary of Terms Used in Health Economics and Pharmacoeconomics and Quality-of-Life Analyses

    Glossary 03 December 2012 Pages: 311 - 314